Novartis appeals IP win for Pharmacor over blood pressure drug

Appeals 2025-01-20 11:42 pm By Christine Caulfield

Make us a preferred source Make us a preferred source on Google

Pharmaceutical giant Novartis is challenging the loss of its case against Sydney-based generics company Pharmacor over a patent for heart medication Entresto.